← Back
$RCKT All transactions

ROCKET PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

30,000

Price

$0

Filed

Jul 18

Insider

Name

Makker Gotham

Title

CIK

0001726391

Roles

Director

Transaction Details

Transaction Date

2025-06-18

Code

A

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

395,912

Footnotes

Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026. | Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $55,000. The RSUs will vest in full on June 18, 2026. | The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein. | The securities may be deemed to be beneficially owned by the reporting person and are held by a non-revocable trust for the benefit of the reporting person's children. The reporting person has no voting or investment power over all securities owned by the trust.

Filing Info

Accession No.

0001140361-25-026408

Form Type

4

Issuer CIK

0001281895

Makker Gotham's History

Date Ticker Type Value
2025-06-18 RCKT A $0
2025-06-18 RCKT A $0

Other Insiders at RCKT (90d)

Insider Bought Sold Last
Militello John
See Remarks
$12K 2026-02-13
Wilson Martin
General Counsel
$41K 2026-02-13
Shah Gaurav
CEO
$41K 2026-02-13
Rizvi Syed Ali-aamir
Chief Medical Officer
2026-02-11
Chaudhuri Sarbani
See Remarks
2026-02-11
Stevens Christopher James
Chief Operating Officer
2026-02-11